Highlights:
-Ablation should be “preferred approach” in drug-resistant ventricular tachycardia
-First randomised trial shows “poor outcomes” with rotor ablation
-Guilherme Fenelon: Ablation in Chagas disease
-Pier Lambiase: EP data
-Advertorial: St. Jude Medical brings to market an automated, flexible and precise solution for cardiac mapping
-Profile: Etienne Aliot
[pdfviewer width=”100%” height=”940px” beta=”true”]https://cardiacrhythmnews.com/wp-content/uploads/sites/12/2016/07/CRN-33_EU_low-res.pdf[/pdfviewer]
